In the present study, we found that low-dose EMAP II inhibited the cell viability and MMP in human GBM cells and GSCs by inducing autophagy, accompanied by the up-regulation of LC3-II and the down-regulation of p62/SQSTM1. The gene discussed is SQSTM1; the disease is glioblastoma.